NRGN and early-onset autosomal dominant Alzheimer disease: Furthermore, neurogranin and other synaptic biomarkers such as Rab3 and SNAP25 were found to predict cognitive decline in patients with Alzheimer’s disease and dementia of Lewy bodies.